Ronald C. Renaud Jr. - 07 Apr 2021 Form 4/A - Amendment Insider Report for Translate Bio, Inc.

Role: Chief Executive Officer, Director
Signature: /s/ Paul Burgess, as attorney-in-fact for Ronald C. Renaud, Jr.
Issuer symbol: N/A
Transactions as of: 07 Apr 2021
Net transactions value: +$66,702
Form type: 4/A - Amendment
Filing time: 14 Sep 2021, 19:31:11 UTC
Date Of Original Report: 09 Apr 2021
Next filing: 09 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBIO	Common Stock	Options Exercise	$66,702	+9,026	+1.8%	$7.39	503,231	07 Apr 2021	Direct	F1
holding	TBIO	Common Stock						409,913	07 Apr 2021	By Ronald Renaud 2014 Irrevocable Family Trust
holding	TBIO	Common Stock						40,909	07 Apr 2021	By Ronald C. Renaud, Jr. Trust - 2007

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Stock Option (right to buy)	Options Exercise	$0	-9,026	-0.84%	$0.000000	1,071,009	07 Apr 2021	Common Stock	9,026	$7.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original Form 4 filed on April 9, 2021 inadvertently reported the incorrect number of securities beneficially owned following the reported transaction by an additional 90 shares. The original Form 4 filed on April 9, 2021 stated that 503,321 shares were owned after the transaction. The correct number of shares is 503,231. This amendment is being filed solely to correct the number of securities beneficially owned.
F2	This option was granted on December 22, 2017. The shares underlying the option vested over four years in equal monthly installments through March 9, 2021.

Content

The original Form 4 filed on April 9, 2021 inadvertently reported the incorrect number of securities beneficially owned following the reported transaction by an additional 90 shares. The original Form 4 filed on April 9, 2021 stated that 503,321 shares were owned after the transaction. The correct number of shares is 503,231. This amendment is being filed solely to correct the number of securities beneficially owned.

This option was granted on December 22, 2017. The shares underlying the option vested over four years in equal monthly installments through March 9, 2021.